BRCA 2016
Blueprint Genetics is attending the Sixth International Symposium on Hereditary Breast and Ovarian Cancer.
Challenges and Opportunities represents a unique opportunity to look at all aspects of breast and ovarian cancer, and in particular the susceptibility genes, BRCA1 and BRCA2, which are responsible for a considerable fraction of early-onset breast cancer.
Topics covered will include the origins, diagnosis and outcome of BRCA-related ovarian cancer, prevention and treatment of HBOC, and new challenges in genetic counseling in the era of panel testing, to name just a few.
Looking forward to meet you there!
Read more about our diagnostics for hereditary breast and ovarian cancer, by clicking here.